Kris Schott

Managing Director and Senior Equity Research Analyst at JPMorgan Chase & Co.

Chris Schott is a Managing Director and Senior Equity Research Analyst at J.P. Morgan specializing in U.S. major and specialty pharmaceuticals, with primary coverage of industry leaders such as Eli Lilly, Pfizer, and other large-cap healthcare companies. He has issued over 650 stock ratings with a majority of Buy recommendations, achieving a 53% success rate and an average return per rating of 1.9% according to TipRanks, and his strong call on Eli Lilly, which rose approximately 190% from 2019 through 2023, is considered one of his top investment ideas. Schott began his Wall Street career at Banc of America Securities before joining J.P. Morgan, where he advanced to Managing Director and leads healthcare sector research initiatives. He holds FINRA securities licenses and has been recognized as a top industry analyst in prominent research rankings, often cited for his in-depth coverage, investment acumen, and impact within the pharmaceutical and healthcare investment community.